DA, H., SE, C., PJ, S., AD, H., Y, B., R, C., . . . PD, T. (2024). Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 78(5), 1103. https://doi.org/10.1093/cid/ciad703
Chicago Style (17th ed.) CitationDA, Hareza, Cosgrove SE, Simner PJ, Harris AD, Bergman Y, Conzemius R, Jacobs E, Beisken S, and Tamma PD. "Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?" Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78, no. 5 (2024): 1103. https://doi.org/10.1093/cid/ciad703.
MLA (9th ed.) CitationDA, Hareza, et al. "Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?" Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 5, 2024, p. 1103, https://doi.org/10.1093/cid/ciad703.